{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:33:15Z","timestamp":1792513995194,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2022JJ70138, 2023JJ20087"],"award-info":[{"award-number":["2022JJ70138, 2023JJ20087"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2022JJ70138, 2023JJ20087"],"award-info":[{"award-number":["2022JJ70138, 2023JJ20087"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82173341"],"award-info":[{"award-number":["No.82173341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01799-0","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:03:13Z","timestamp":1724752993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tumor-associated macrophage-derived itaconic acid contributes to nasopharyngeal carcinoma progression by promoting immune escape via TET2"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaowei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen\u2019er","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping\u2019an","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benquan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuozhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"4","key":"1799_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up(\u2020). Ann Oncol. 2021;32(4):452\u201365.","journal-title":"Ann Oncol"},{"key":"1799_CR2","doi-asserted-by":"crossref","unstructured":"Chiang CL, Guo Q, Ng WT, Lin S, Ma TSW, Xu Z, et al. Prognostic factors for overall survival in nasopharyngeal Cancer and implication for TNM staging by UICC: a systematic review of the literature. Front Oncol. 2021;11:703995.","DOI":"10.3389\/fonc.2021.703995"},{"issue":"3","key":"1799_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"6230","key":"1799_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"issue":"1","key":"1799_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6(1):75.","journal-title":"Signal Transduct Target Ther"},{"key":"1799_CR6","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-Associated macrophages in Tumor Immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"issue":"10","key":"1799_CR7","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-21-4260","volume":"82","author":"YT Wei","year":"2022","unstructured":"Wei YT, Wang XR, Yan C, Huang F, Zhang Y, Liu X, et al. Thymosin \u03b1-1 reverses M2 polarization of Tumor-Associated macrophages during Efferocytosis. Cancer Res. 2022;82(10):1991\u20132002.","journal-title":"Cancer Res"},{"issue":"12","key":"1799_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1568026623666230201145909","volume":"23","author":"HA Lafta","year":"2023","unstructured":"Lafta HA, AbdulHussein AH, Al-Shalah SAJ, Alnassar YS, Mohammed NM, Akram SM, et al. Tumor-associated macrophages (TAMs) in Cancer Resistance; modulation by Natural products. Curr Top Med Chem. 2023;23(12):1104\u201322.","journal-title":"Curr Top Med Chem"},{"key":"1799_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","volume":"11","author":"K Wu","year":"2020","unstructured":"Wu K, Lin K, Li X, Yuan X, Xu P, Ni P, et al. Redefining Tumor-Associated macrophage subpopulations and functions in the Tumor Microenvironment. Front Immunol. 2020;11:1731.","journal-title":"Front Immunol"},{"issue":"19","key":"1799_CR10","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A. 2013;110(19):7820\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1799_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao H, Teng D, Yang L, Xu X, Chen J, Jiang T, et al. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab. 2022;4(12):1660\u201373.","journal-title":"Nat Metab"},{"issue":"1","key":"1799_CR12","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1038\/s41467-023-43988-4","volume":"14","author":"X Gu","year":"2023","unstructured":"Gu X, Wei H, Suo C, Shen S, Zhu C, Chen L, et al. Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8(+) T-cell exhaustion. Nat Commun. 2023;14(1):8154.","journal-title":"Nat Commun"},{"issue":"9","key":"1799_CR13","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1172\/JCI99169","volume":"128","author":"JM Weiss","year":"2018","unstructured":"Weiss JM, Davies LC, Karwan M, Ileva L, Ozaki MK, Cheng RY, et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest. 2018;128(9):3794\u2013805.","journal-title":"J Clin Invest"},{"issue":"63","key":"1799_CR14","doi-asserted-by":"publisher","first-page":"32098","DOI":"10.18632\/oncotarget.25956","volume":"9","author":"J Meiser","year":"2018","unstructured":"Meiser J, Kraemer L, Jaeger C, Madry H, Link A, Lepper PM, et al. Itaconic acid indicates cellular but not systemic immune system activation. Oncotarget. 2018;9(63):32098\u2013107.","journal-title":"Oncotarget"},{"issue":"4","key":"1799_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"17","key":"1799_CR16","doi-asserted-by":"publisher","first-page":"eadg0654","DOI":"10.1126\/sciadv.adg0654","volume":"9","author":"YJ Chen","year":"2023","unstructured":"Chen YJ, Li GN, Li XJ, Wei LX, Fu MJ, Cheng ZL, et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Sci Adv. 2023;9(17):eadg0654.","journal-title":"Sci Adv"},{"issue":"3","key":"1799_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","volume":"24","author":"LL Chen","year":"2022","unstructured":"Chen LL, Morcelle C, Cheng ZL, Chen X, Xu Y, Gao Y, et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat Cell Biol. 2022;24(3):353\u201363.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"1799_CR18","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23(8):1148\u201356.","journal-title":"Nat Immunol"},{"issue":"41","key":"1799_CR19","doi-asserted-by":"publisher","first-page":"e202207508","DOI":"10.1002\/anie.202207508","volume":"61","author":"ND Barth","year":"2022","unstructured":"Barth ND, Van Dalen FJ, Karmakar U, Bertolini M, Mendive-Tapia L, Kitamura T, et al. Enzyme-activatable chemokine conjugates for in vivo targeting of Tumor-Associated macrophages. Angew Chem Int Ed Engl. 2022;61(41):e202207508.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"1799_CR20","doi-asserted-by":"publisher","first-page":"e202217089","DOI":"10.1002\/anie.202217089","volume":"62","author":"L Zhang","year":"2023","unstructured":"Zhang L, Lin Y, Li S, Guan X, Jiang X. In situ reprogramming of Tumor-Associated macrophages with internally and externally Engineered exosomes. Angew Chem Int Ed Engl. 2023;62(11):e202217089.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1799_CR21","doi-asserted-by":"publisher","first-page":"120601","DOI":"10.1016\/j.biomaterials.2020.120601","volume":"268","author":"H Li","year":"2021","unstructured":"Li H, Somiya M, Kuroda S. Enhancing antibody-dependent cellular phagocytosis by re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes. Biomaterials. 2021;268:120601.","journal-title":"Biomaterials"},{"key":"1799_CR22","doi-asserted-by":"crossref","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization States in the Tumor Microenvironment. Int J Mol Sci 2021; 22(13).","DOI":"10.3390\/ijms22136995"},{"key":"1799_CR23","doi-asserted-by":"publisher","first-page":"994319","DOI":"10.3389\/fimmu.2022.994319","volume":"13","author":"M Patysheva","year":"2022","unstructured":"Patysheva M, Frolova A, Larionova I, Afanas\u2019ev S, Tarasova A, Cherdyntseva N, et al. Monocyte programming by cancer therapy. Front Immunol. 2022;13:994319.","journal-title":"Front Immunol"},{"issue":"24","key":"1799_CR24","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.116.025490","volume":"135","author":"VC Ganta","year":"2017","unstructured":"Ganta VC, Choi MH, Kutateladze A, Fox TE, Farber CR, Annex BH. A MicroRNA93-Interferon Regulatory factor-9-Immunoresponsive gene-1-Itaconic acid pathway modulates M2-Like Macrophage polarization to Revascularize ischemic muscle. Circulation. 2017;135(24):2403\u201325.","journal-title":"Circulation"},{"key":"1799_CR25","doi-asserted-by":"publisher","first-page":"114935","DOI":"10.1016\/j.bcp.2022.114935","volume":"198","author":"L Ni","year":"2022","unstructured":"Ni L, Lin Z, Hu S, Shi Y, Jiang Z, Zhao J, et al. Itaconate attenuates osteoarthritis by inhibiting STING\/NF-\u03baB axis in chondrocytes and promoting M2 polarization in macrophages. Biochem Pharmacol. 2022;198:114935.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1799_CR26","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1039\/D2BM01894B","volume":"11","author":"H Xiao","year":"2023","unstructured":"Xiao H, Dong Y, Wan D, Wan J, Huang J, Tang L, et al. Injectable hydrogel loaded with 4-octyl itaconate enhances cartilage regeneration by regulating macrophage polarization. Biomater Sci. 2023;11(7):2445\u201360.","journal-title":"Biomater Sci"},{"key":"1799_CR27","doi-asserted-by":"publisher","first-page":"115614","DOI":"10.1016\/j.bcp.2023.115614","volume":"213","author":"X Duan","year":"2023","unstructured":"Duan X, Hu M, Yang L, Zhang S, Wang B, Li T, et al. IRG1 prevents excessive inflammatory responses and cardiac dysfunction after myocardial injury. Biochem Pharmacol. 2023;213:115614.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1799_CR28","doi-asserted-by":"publisher","first-page":"112145","DOI":"10.1016\/j.celrep.2023.112145","volume":"42","author":"W Li","year":"2023","unstructured":"Li W, Li Y, Kang J, Jiang H, Gong W, Chen L, et al. 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. Cell Rep. 2023;42(3):112145.","journal-title":"Cell Rep"},{"issue":"5","key":"1799_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","volume":"19","author":"LAJ O\u2019Neill","year":"2019","unstructured":"O\u2019Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol. 2019;19(5):273\u201381.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1799_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2016.08.013","volume":"24","author":"HH Luan","year":"2016","unstructured":"Luan HH, Medzhitov R. Food Fight: role of Itaconate and other metabolites in Antimicrobial Defense. Cell Metab. 2016;24(3):379\u201387.","journal-title":"Cell Metab"},{"issue":"34","key":"1799_CR31","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/sj.onc.1209594","volume":"25","author":"A King","year":"2006","unstructured":"King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene. 2006;25(34):4675\u201382.","journal-title":"Oncogene"},{"issue":"6621","key":"1799_CR32","doi-asserted-by":"publisher","first-page":"eabl7207","DOI":"10.1126\/science.abl7207","volume":"378","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Saghafinia S, Chryplewicz A, Fournier N, Christe L, Xie YQ, et al. Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 2022;378(6621):eabl7207.","journal-title":"Science"},{"issue":"5","key":"1799_CR33","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.7150\/thno.68864","volume":"12","author":"CH Lee","year":"2022","unstructured":"Lee CH, Bae JH, Choe EJ, Park JM, Park SS, Cho HJ, et al. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1. Theranostics. 2022;12(5):1971\u201387.","journal-title":"Theranostics"},{"key":"1799_CR34","doi-asserted-by":"crossref","unstructured":"Sun P, Zhang X, Wang RJ, Ma QY, Xu L, Wang Y et al. PI3K\u03b1 inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8(+)T cells and promoting fatty acid metabolism. J Immunother Cancer. 2021;9(8):e003093.","DOI":"10.1136\/jitc-2021-003093"},{"issue":"1","key":"1799_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s42003-020-01391-5","volume":"3","author":"S Jiang","year":"2020","unstructured":"Jiang S. Tet2 at the interface between cancer and immunity. Commun Biol. 2020;3(1):667.","journal-title":"Commun Biol"},{"issue":"1","key":"1799_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","volume":"105","author":"S Chiba","year":"2017","unstructured":"Chiba S. Dysregulation of TET2 in hematologic malignancies. Int J Hematol. 2017;105(1):17\u201322.","journal-title":"Int J Hematol"},{"issue":"11","key":"1799_CR37","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1158\/0008-5472.CAN-21-3013","volume":"82","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li S, He J, Jin Y, Zhang R, Dong W, et al. TET2 suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by inhibiting HIF Signaling. Cancer Res. 2022;82(11):2097\u2013109.","journal-title":"Cancer Res"},{"issue":"8","key":"1799_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Xue M, Deng X, Dong L, Nguyen LXT, Ren L, et al. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal. Cell Stem Cell. 2023;30(8):1072\u2013e10901010.","journal-title":"Cell Stem Cell"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01799-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:10:42Z","timestamp":1724753442000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01799-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01799-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols were reviewed and approved by the Joint Ethics Committee of the Third Xiangya Hospital, the Central South University Health Authority and performed in accordance with national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This manuscript has been read and approved by all the authors to publish and is not submitted or under consideration for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}